EUVIMEDEUVIMED entdecken
Systematische Übersicht

Topical hemostatic agents in endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review

Ian M Gralnek, Pradeep Bhandari, Asma Alkandari, Ali Alali iD, Rehan J Haidry, Apostolis Papaefthymiou iD, Franco Radaelli iD, Sharmila Subramaniam iD, Lorenzo Fuccio iD

Endoscopy · 2025-10 · 57 (10) · 1150-1173

DOI: 10.1055/a-2646-7556 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Endoscopy, online erschienen am 30.07.2025. Verfasst von Ian M Gralnek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ellen and Pinchas Mamber Institute of Gastroenterology and Hepatology, Emek Medical Center, Afula, Israel. Hauptthemen laut MEDLINE: Hemostatics, Gastrointestinal Hemorrhage, Endoscopy, Gastrointestinal, Hemostasis, Endoscopic. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 107 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal (GI) endoscopy has evolved from a diagnostic tool into a therapeutic modality, leading to a higher incidence of bleeding complications during and after procedures. To address this issue, various hemostatic agents have been developed, including injectable, mechanical, thermal, and topical products. Topical hemostatic agents, available in powder or gel forms, can be used as standalone treatments or as adjuncts to traditional hemostatic therapies to control or prevent bleeding. This Technical and Technology Review examines the commercially available topical hemostatic agents used in endoscopy, specifically Purastat, TC-325 Hemospray, EndoClot PHS, Nexpowder, Ankaferd Blood Stopper, and CG GEL. A systematic literature review was conducted up to January 2025, focusing on randomized controlled trials (RCTs), meta-analyses, and observational studies. Each product was assessed for its composition, mechanism of action, regulatory status, mode of use, efficacy, safety, and financial considerations. Purastat showed 94% efficacy in acute GI bleeding, reducing delayed bleeding to 4.3% in endoscopic submucosal dissection (ESD) and endoscopic mucosal resection cases, with significantly lower thermal device usage. TC-325 Hemospray achieved 85%–98.5% primary hemostasis in upper and lower GI bleeding, with pooled hemostasis rates of 93.1% and rebleeding rates of 8.9%. It was also effective in malignancy-related bleeding, with hemostasis success up to 100%. EndoClot PHS demonstrated 76%–100% hemostasis efficacy, comparable with TC-325, with rebleeding rates of 24%–25%. It showed prophylactic potential post-ESD, with rebleeding rates of 7.3%–9.1%. Nexpowder achieved 94% hemostasis in refractory upper GI bleeds and reduced rebleeding in lower GI bleeds to 5.5% at 28 days. Ankaferd Blood Stopper demonstrated 73%–100% hemostasis across various GI bleeding sources, including peptic ulcers and malignancies, though further data on rebleeding are needed. Topical hemostatic agents offer effective options for managing GI bleeding. Products like Purastat, TC-325 Hemospray, EndoClot PHS, Nexpowder, Ankaferd Blood Stopper, and CG GEL have shown promising results in achieving hemostasis; however, further RCTs and cost-effectiveness analyses are needed to better establish their roles in endoscopic practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemostaticsGastrointestinal HemorrhageEndoscopy, GastrointestinalHemostasis, EndoscopicHumansAdministration, TopicalPlant ExtractsMinerals

Substanzen

Hemostaticshemosprayankaferd blood stopperPlant ExtractsMinerals

Autor:innen und Institutionen

  • Ellen and Pinchas Mamber Institute of Gastroenterology and Hepatology, Emek Medical Center, Afula, Israel.
  • Rappaport Faculty of Medicine Technion Israel Institute of Technology, Haifa, Israel.
  • Department of Gastroenterology, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
  • Mayo Clinic, London, United Kingdom.
  • Al Jahra Hospital, Kuwait, Kuwait.
  • Thunayan Alghanim Gastroenterology Center, Amiri Hospital, Sharq, Kuwait.

ORCID-Profile: Ali Alali, Apostolis Papaefthymiou, Franco Radaelli, Sharmila Subramaniam, Lorenzo Fuccio

Zitieren

APA

Gralnek, I. M., Bhandari, P., Alkandari, A., Alali, A., Haidry, R. J., Papaefthymiou, A., Radaelli, F., Subramaniam, S., & Fuccio, L. (2025). Topical hemostatic agents in endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review. Endoscopy, 57(10), 1150-1173. https://doi.org/10.1055/a-2646-7556

Vancouver

Gralnek IM, Bhandari P, Alkandari A, Alali A, Haidry RJ, Papaefthymiou A, et al. Topical hemostatic agents in endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review. Endoscopy. 2025;57(10):1150-1173. doi:10.1055/a-2646-7556

BibTeX
@article{Gralnek2025,
  author = {Gralnek, Ian M and Bhandari, Pradeep and Alkandari, Asma and Alali, Ali and Haidry, Rehan J and Papaefthymiou, Apostolis and Radaelli, Franco and Subramaniam, Sharmila and Fuccio, Lorenzo},
  title = {Topical hemostatic agents in endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review},
  journal = {Endoscopy},
  year = {2025},
  volume = {57},
  number = {10},
  pages = {1150--1173},
  doi = {10.1055/a-2646-7556}
}
Kostenlos starten →